Back to MI Meitav Investment House Ltd
ATOS
Showing 0 of 2 quarters
Position history for MIMeitav Investment House Ltd's holdings in Atossa Therapeutics, Inc.
No. Meitav Investment House exited its ATOS (Atossa Therapeutics) position in Q2 2021. Its Q1 2021 13F listed 30,000 shares worth $63,000. Meitav Investment House first reported ATOS in Q1 2021 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
—
No position history available for this security.
Other major holders of ATOS: Susquehanna International Group, LLP, BlackRock, Inc., State Street Corp., Geode Capital Management, LLC, Invesco Ltd.